Company profile for AuroMedics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are vertically integrated-developing the majority of our products in-house and utilizing our dedicated development and regulatory affairs teams. As a result, we can maximize efficiency and provide a consistent supply of high-quality products at reasonable prices.AuroMedics, we take the customer experience seriously and pride ourselves on our ability to anticipate our customers’ every need. We do not use contract manufact...
We are vertically integrated-developing the majority of our products in-house and utilizing our dedicated development and regulatory affairs teams. As a result, we can maximize efficiency and provide a consistent supply of high-quality products at reasonable prices.AuroMedics, we take the customer experience seriously and pride ourselves on our ability to anticipate our customers’ every need. We do not use contract manufacturers or third-party logistics firms to manage our customer service.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
279 Princeton Hightstown Rd, East Windsor, NJ 08520
Telephone
Telephone
888-238-7880
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eugia-us-llc-fka-auromedics-pharma-llc-issues-voluntary-nationwide-recall-methocarbamol-injection

FDA
28 Mar 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-11-2023-52259.pdf

FDA
11 Jan 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-2-2022-77418.pdf

FDA
02 Nov 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-26-2022-89071.pdf

FDA
26 Oct 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-12-2022-83607.pdf

FDA
12 Oct 2022

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eugia-us-llc-issues-voluntary-nationwide-recall-acyclovir-sodium-injection-500-mg-10-ml-50-mgml-due

FDA
28 Sep 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty